Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Bone Neoplasms × Curettage × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Basal Cell 4 Chalazion 2 Recurrence 1 Pilonidal Sinus 1 Pain 1 Endometrial Neoplasms 1 Chondrosarcoma 1 Chondroma 1 Carcinoma, Squamous Cell 1 Bone Neoplasms 1 Bone Cysts 1

Interventions

Ibandronic Acid 8 Gemcitabine 7 Doxorubicin 6 Radiation 4 Irinotecan 4 Cyclophosphamide 4 pembrolizumab 3 Zoledronic Acid 3 Vincristine 3 Temozolomide 3 Nivolumab 3 Magnetic Resonance Spectroscopy 3 Docetaxel 3 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 3 pegfilgrastim 2 Tranexamic Acid 2 Trabectedin 2 Surveys and Questionnaires 2 Sunitinib 2 Standard of Care 2 Radiotherapy, Intensity-Modulated 2 Radiotherapy 2 Observation 2 Methotrexate 2 Methods 2 Ipilimumab 2 Interviews as Topic 2 Injections 2 Indocyanine Green 2 Ifosfamide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02996747 2016-12-22

CONDRO1

Istituto Ortopedico Rizzoli

Bone Neoplasms, Chondroma, Chondrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡